<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17369" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Allergic and Drug-Induced Interstitial Nephritis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Finnigan</surname>
            <given-names>Nancy A.</given-names>
          </name>
          <aff>Campbell University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rout</surname>
            <given-names>Preeti</given-names>
          </name>
          <aff>Wilson Case Western University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leslie</surname>
            <given-names>Stephen W.</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bashir</surname>
            <given-names>Khalid</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nancy Finnigan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Preeti Rout declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephen Leslie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Khalid Bashir declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17369.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Drug-induced acute interstitial nephritis (DI-AIN), also called allergic acute interstitial nephritis, is the most common cause of acute interstitial nephritis (AIN) in developed countries. DI-AIN is associated with a sharp decline in renal function, often requiring dialysis, and has the potential for permanent renal insufficiency, especially if left untreated. Differentiating from other causes of acute kidney injury and discontinuing the causative medication is key to early reversibility. Renal biopsy is the definitive diagnostic test for AIN, and barring chronic changes seen on biopsy or contraindications, steroid therapy is the preferred treatment. This activity discusses the etiology, pathophysiology, clinical symptomatology, and treatment&#x000a0;while emphasizing&#x000a0;the interprofessional team's role in managing allergic interstitial nephritis.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify potential allergic and drug-induced acute interstitial nephritis cases by recognizing varied presentations and conducting a thorough medication history review.</p></list-item><list-item><p>Differentiate allergic and drug-induced acute interstitial nephritis from other causes of acute kidney injury through clinical assessment, laboratory investigations, and renal biopsy if indicated.</p></list-item><list-item><p>Apply evidence-based guidelines for the treatment of allergic and drug-induced acute interstitial nephritis, including the judicious use of corticosteroids when indicated, weighing the potential benefits against risks.</p></list-item><list-item><p>Coordinate care and follow-up for patients with allergic and drug-induced acute interstitial nephritis to monitor renal function, medication adjustments, and potential long-term consequences, aiming for optimal outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17369&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17369">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17369.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Drug-induced acute interstitial nephritis (DI-AIN), also called allergic acute interstitial nephritis, is the most common cause of acute interstitial nephritis (AIN) in developed countries. DI-AIN is associated with a sharp decline in renal function, often requiring dialysis, and has the potential for permanent renal insufficiency, especially if left untreated. Differentiating from other causes of acute kidney injury and discontinuing the causative medication is key to early reversibility.&#x000a0;</p>
        <p>Interstitial nephritis was first described in 1898 by William Thomas Councilman, chief pathologist at Brigham Hospital, who noted nonsuppurative interstitial lesions on autopsies of patients with streptococcal infections, and this term is used to describe various immune-mediated kidney disorders that cause significant inflammatory cell infiltration of the renal interstitium and tubules while sparing the glomeruli.<xref ref-type="bibr" rid="article-17369.r1">[1]</xref><xref ref-type="bibr" rid="article-17369.r2">[2]</xref><xref ref-type="bibr" rid="article-17369.r3">[3]</xref>&#x000a0;</p>
        <p>The most common form of AIN in developed countries is caused by drug exposure, estimated at 70% to 75% of cases. DI-AIN is a frequent causative agent of acute kidney injury (AKI), responsible for about 20% of renal biopsies performed for unexplained AKI.<xref ref-type="bibr" rid="article-17369.r1">[1]</xref>&#x000a0;AIN is associated with an acute decline in renal function and may progress to permanent renal insufficiency or even end-stage renal disease (ESRD).<xref ref-type="bibr" rid="article-17369.r3">[3]</xref>&#x000a0;AIN has been defined as an increase of 0.5 mg/dL or 50% in serum creatinine over a 24- to 72-hour period starting 24 to 48 hours after exposure to a potential triggering medication.<xref ref-type="bibr" rid="article-17369.r4">[4]</xref><xref ref-type="bibr" rid="article-17369.r5">[5]</xref>&#x000a0;</p>
        <p>The classic clinical presentation of AIN characterized by fever, rash, and eosinophilia was prominently associated with methicillin use, which occurred in about 17% of cases. However, this specific presentation is less common with other medications known to cause AIN.<xref ref-type="bibr" rid="article-17369.r6">[6]</xref> Identification and discontinuation of the offending medication are the mainstays of treatment, with conflicting evidence regarding the benefit of steroid treatment.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref><xref ref-type="bibr" rid="article-17369.r8">[8]</xref><xref ref-type="bibr" rid="article-17369.r9">[9]</xref><xref ref-type="bibr" rid="article-17369.r10">[10]</xref>&#x000a0;With early recognition and proper treatment, AIN and its associated renal failure are generally reversible.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref></p>
        <p>For information on other causes of interstitial nephritis (genetic, idiopathic, infectious, immune-mediated, and associated with various systemic inflammatory disorders), as well as anti-tubular basement membrane disease and tubulointerstitial nephritis and uveitis syndrome (TINU), see our companion StatPearls reference article on <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/ArticleLibrary/viewarticle/30673">Tubulointerstitial Nephritis</ext-link>.&#x000a0;Autosomal dominant tubulointerstitial kidney disease is also described elsewhere.<xref ref-type="bibr" rid="article-17369.r11">[11]</xref><xref ref-type="bibr" rid="article-17369.r12">[12]</xref></p>
      </sec>
      <sec id="article-17369.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>NSAIDs are the most common class of drugs causing DI-AIN, responsible for 44% of cases.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref><xref ref-type="bibr" rid="article-17369.r10">[10]</xref><xref ref-type="bibr" rid="article-17369.r13">[13]</xref><xref ref-type="bibr" rid="article-17369.r14">[14]</xref><xref ref-type="bibr" rid="article-17369.r15">[15]</xref>&#x000a0;Antibiotics such as penicillins, cephalosporins, rifampin, sulfonamides, and ciprofloxacin account for about 33% of DI-AIN.<xref ref-type="bibr" rid="article-17369.r13">[13]</xref>&#x000a0;</p>
        <p>Different medication classes causing DI-AIN have distinct presentations and are associated with specific patient demographics.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>NSAIDs</bold>&#x000a0;are very commonly used both as a prescription and over-the-counter. Patients with NSAID-induced AIN tend to be older than 50 years and are frequently chronic users with significant comorbidities or some degree of preexisting renal dysfunction.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref> Associated characteristics of Allergic Interstitial Nephritis (AIN) include significant proteinuria, which may even reach nephrotic range levels (3 grams or more of urinary protein per day), longer latency periods, less complete renal recovery, and minimal change disease. Clinical presentation is less likely to show eosinophilia, eosinophiluria, rashes, fevers, hematuria, or arthralgias than patients with AIN from other triggering drugs.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r16">[16]</xref><xref ref-type="bibr" rid="article-17369.r17">[17]</xref>&#x000a0;All NSAIDs can produce AIN, but nonselective agents, such as aspirin, ibuprofen, and sulindac, tend to produce less DI-AIN.<xref ref-type="bibr" rid="article-17369.r18">[18]</xref><xref ref-type="bibr" rid="article-17369.r19">[19]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Proton pump inhibitors</bold> are an increasing cause of AIN, with an estimated 12/100,000 population incidence.<xref ref-type="bibr" rid="article-17369.r20">[20]</xref>&#x000a0;In some studies, they are the second most common underlying trigger for DI-AIN.<xref ref-type="bibr" rid="article-17369.r21">[21]</xref><xref ref-type="bibr" rid="article-17369.r22">[22]</xref>&#x000a0;The severity of AIN from proton pump inhibitors is somewhat less than from other medications, such as antibiotics, but the likelihood of recovery is also reduced.<xref ref-type="bibr" rid="article-17369.r23">[23]</xref><xref ref-type="bibr" rid="article-17369.r24">[24]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Beta-lactams</bold>&#x000a0;are the class of drugs most likely to demonstrate the classic triad of symptoms (fever, rash, and arthralgias), produce eosinophilia, and develop a pure form of allergic/hypersensitivity reaction histologically. Patients with a prior penicillin or cephalosporin reaction are more likely to develop this.<xref ref-type="bibr" rid="article-17369.r25">[25]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Immune checkpoint inhibitors </bold>are&#x000a0;monoclonal antibodies used for cancer therapy and are an increasingly significant cause of AIN.<xref ref-type="bibr" rid="article-17369.r26">[26]</xref>&#x000a0;Clinical and histological presentations are similar to other cases of AIN, but patients tend to have a longer latency period, reduced level of AKI, and a slower recovery of renal function.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r27">[27]</xref>&#x000a0;There also appears to be an association with the simultaneous use of proton pump inhibitors.<xref ref-type="bibr" rid="article-17369.r28">[28]</xref><xref ref-type="bibr" rid="article-17369.r29">[29]</xref><xref ref-type="bibr" rid="article-17369.r30">[30]</xref><xref ref-type="bibr" rid="article-17369.r31">[31]</xref>&#x000a0;AIN from immune checkpoint inhibitors&#x000a0;poses a significant therapeutic dilemma since there are no reasonable alternative medications for many cancer patients, making it difficult or impossible to discontinue the offending drug safely.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r32">[32]</xref><xref ref-type="bibr" rid="article-17369.r15">[15]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Other drug classes</bold> that have demonstrated a tendency to produce AIN include sulfa drugs, tyrosine kinase inhibitors, antiepileptics (phenytoin), antivirals, and histamine-2 antagonists.<xref ref-type="bibr" rid="article-17369.r4">[4]</xref></p>
          </list-item>
        </list>
        <p>Numerous case reports in the literature regarding other medication culprits demonstrate&#x000a0;the need for ongoing consideration of DI-AIN as a potential cause of worsening renal function after initiation of drug therapy. More than 250 drugs have been described as triggering agents for DI-AIN.<xref ref-type="bibr" rid="article-17369.r33">[33]</xref>&#x000a0;Polypharmacy, particularly in the&#x000a0;older population, can make identification of the causative agent challenging in many cases.<xref ref-type="bibr" rid="article-17369.r34">[34]</xref><xref ref-type="bibr" rid="article-17369.r35">[35]</xref><xref ref-type="bibr" rid="article-17369.r36">[36]</xref><xref ref-type="bibr" rid="article-17369.r37">[37]</xref></p>
      </sec>
      <sec id="article-17369.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The frequency of&#x000a0;AIN and DI-AIN is likely underestimated, as the diagnosis can only be definitively confirmed with the histological evaluation from a renal biopsy.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref>&#x000a0;In practice, renal biopsies are often deferred&#x000a0;as clinical suspicion often guides therapy, especially if the patient's symptoms and renal function improve within&#x000a0;7 days of drug discontinuation.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref>&#x000a0;Given the lack of solid evidence to pursue immunosuppressant therapy, a biopsy often does not change the treatment plan beyond discontinuing the likely offending agent.</p>
        <p>The increased use of NSAIDs, antibiotics, and proton pump inhibitors in most countries globally has contributed to a worldwide increase in DI-AIN diagnosis, even though it represents less than fifteen percent of all reported adverse drug reactions.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r33">[33]</xref>&#x000a0;Older patients are particularly susceptible to AIN due to chronic use of triggering medications, preexisting renal disorders, and polypharmacy.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r38">[38]</xref>&#x000a0;The most common triggers are NSAIDs, proton pump inhibitors, and penicillins, while systemic causes are less likely in older AIN patients.<xref ref-type="bibr" rid="article-17369.r23">[23]</xref><xref ref-type="bibr" rid="article-17369.r38">[38]</xref>&#x000a0;</p>
        <p>Older patients with AIN are more likely to have preexisting chronic kidney disease, higher baseline creatinine levels, increased levels of proteinuria, and a greater need for dialysis than younger patients.<xref ref-type="bibr" rid="article-17369.r23">[23]</xref><xref ref-type="bibr" rid="article-17369.r39">[39]</xref>&#x000a0;Although more likely to develop AIN, older patients may not be considered good candidates for a renal biopsy for various reasons, which may cause the overall prevalence to be further underestimated in this population group.&#x000a0;</p>
      </sec>
      <sec id="article-17369.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Renal parenchyma is prone to cellular damage for many reasons, including high metabolic activity with a relatively limited blood supply, greater exposure to higher concentrations of drugs than other organs, active tubule transport systems further increasing drug exposure, and a high osmotic environment.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref><xref ref-type="bibr" rid="article-17369.r40">[40]</xref>&#x000a0;Several mechanisms of inflammatory pathway activation appear to be involved, including hapten-mediated immune activation, direct drug stimulation of T-cells, medication-induced renal tubular cell damage, tubular crystallization of medications, and antibody-mediated cellular injury.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref></p>
        <p>The underlying pathophysiology of DI-AIN is thought to be a type IV idiosyncratic T-cell&#x02013;mediated delayed hypersensitivity reaction.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r41">[41]</xref>&#x000a0;It is primarily a cell-mediated immunological process, as evidenced by high numbers of activated T-cells in renal biopsies of DI-AIN patients.<xref ref-type="bibr" rid="article-17369.r42">[42]</xref>&#x000a0;Drug-specific T-cells have also been identified in the renal interstitium of biopsy-proven DI-AIN patients in research settings.<xref ref-type="bibr" rid="article-17369.r43">[43]</xref><xref ref-type="bibr" rid="article-17369.r44">[44]</xref></p>
        <p>Haptens are small molecules that become immunogenic only when attached to a larger molecule, most often a protein. Drugs causing AIN are endocytosed by interstitial or tubular cells, becoming haptens.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r33">[33]</xref><xref ref-type="bibr" rid="article-17369.r42">[42]</xref><xref ref-type="bibr" rid="article-17369.r43">[43]</xref><xref ref-type="bibr" rid="article-17369.r45">[45]</xref>&#x000a0;As the tubular epithelial cells process the drug haptens, adjacent renal interstitial dendritic cells near the basolateral basement membrane are mobilized and migrate to the regional lymph nodes to activate T-cells further.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r46">[46]</xref>&#x000a0;These activated T-cells eventually reach the damaged renal tubular cells and produce cytokines and proinflammatory chemokines.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r47">[47]</xref>&#x000a0;The initiation of the inflammatory process results in fibroblast proliferation, macrophage migration, and localized edema, producing AIN's characteristic inflammatory interstitial infiltrate.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r47">[47]</xref>&#x000a0;</p>
        <p>Several drugs can also directly cause local and regional T-cell stimulation and activation.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r45">[45]</xref><xref ref-type="bibr" rid="article-17369.r48">[48]</xref>&#x000a0;Others may cause kidney tubular damage directly or indirectly via cross-reactivity between some medications, the renal tubular basement membrane (TBM), and interstitial antigens.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r49">[49]</xref><xref ref-type="bibr" rid="article-17369.r50">[50]</xref><xref ref-type="bibr" rid="article-17369.r51">[51]</xref>&#x000a0;</p>
        <p>Some medications or their metabolites are relatively insoluble in the urine, resulting in drug crystal precipitation in the distal tubular lumens. This causes renal tubular obstruction and injury, as well as localized inflammation resulting in AKI and AIN.<xref ref-type="bibr" rid="article-17369.r52">[52]</xref>&#x000a0;Examples of drugs with poor urinary solubility include antibiotics (ampicillin, ciprofloxacin, sulfonamides), antivirals (acyclovir, indinavir),&#x000a0;methotrexate, and triamterene.<xref ref-type="bibr" rid="article-17369.r4">[4]</xref></p>
        <p>Although the predominant pathophysiology of AIN is related to cytotoxic T-cell activity, antibody-mediated cellular injury is sometimes involved.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref>&#x000a0;Methicillin, for example, is associated with granular immune complex deposition on the tubular basement membrane and a TBM-specific hapten.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r53">[53]</xref>&#x000a0;Similarly, AIN from rifampin demonstrates anti-rifampin antibodies.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref></p>
        <p>There also appears to be an association between some human leukocyte antigen (HLA) histocompatibility genotypes and AIN.<xref ref-type="bibr" rid="article-17369.r54">[54]</xref>&#x000a0;Specifically, individuals with greater HLA-DR and HLA-DQ expression showed a positive correlation with the risk of AIN, DI-AIN severity, and increased interstitial T-lymphocyte infiltration.<xref ref-type="bibr" rid="article-17369.r54">[54]</xref><xref ref-type="bibr" rid="article-17369.r55">[55]</xref></p>
        <p>In severe, chronic cases, extensive fibroblastic infiltration is associated with increased extracellular matrix production, which promotes further renal tubular cellular damage, ultimately leading to tubulointerstitial fibrosis, tubular atrophy, and chronic kidney disease.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r43">[43]</xref></p>
      </sec>
      <sec id="article-17369.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>DI-AIN can be definitively diagnosed only by renal biopsy, characterized by an inflammatory infiltrate in the renal interstitium and tubules that typically does not involve the glomeruli.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref><xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r41">[41]</xref>&#x000a0;Light microscopy shows interstitial inflammation with a predominance of T-lymphocytes, both CD4+ and CD8+, along with eosinophils, whose presence near the tubular basement membrane is diagnostic of AIN. Neutrophils and plasma cells may also be present. The inflammatory infiltrate is typically associated with interstitial edema and tubulitis. An altered brush border, prominent nucleoli, cytoplasmic vacuolization, tubular dilation, and disruption of the tubular basement membrane characterize Tubulitis. Immunofluorescence will usually not show a specific immunoglobulin or complement pattern, and electron microscopy is useful in diagnosing NSAID-induced AIN, causing a minimal change in disease.<xref ref-type="bibr" rid="article-17369.r43">[43]</xref><xref ref-type="bibr" rid="article-17369.r56">[56]</xref></p>
        <p>The glomeruli and renal vasculature are usually not involved, and fibrosis is minimal unless exposure has been ongoing and chronic interstitial nephritis has developed.&#x000a0;Older AIN patients tend to have more tubular atrophy, fibrosis, and sclerotic glomeruli.<xref ref-type="bibr" rid="article-17369.r23">[23]</xref>&#x000a0;The presence of fibrosis or tubular atrophy indicates that steroids may not be helpful, as the acute inflammatory phase (which steroids suppress) has been completed.<xref ref-type="bibr" rid="article-17369.r57">[57]</xref>&#x000a0;<xref ref-type="bibr" rid="article-17369.r58">[58]</xref>&#x000a0;</p>
        <p>Granulomatous interstitial nephritis is a less common presentation of DI-AIN. It is associated with NSAIDs and antimicrobials like vancomycin or ciprofloxacin. Granulomas are formed by macrophages and multinucleated giant cells, often due to the inability to eradicate the offending antigen.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref></p>
      </sec>
      <sec id="article-17369.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The initial workup should include a thorough history and physical examination with particular attention to over-the-counter medications such as NSAIDs, proton pump inhibitors, and any recently introduced drugs.&#x000a0;Symptoms&#x000a0;may appear within a few days or be delayed weeks or months after exposure to the triggering medication.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref>&#x000a0;Earlier presentation is typically associated with prior exposure to the offending drugs.<xref ref-type="bibr" rid="article-17369.r59">[59]</xref><xref ref-type="bibr" rid="article-17369.r60">[60]</xref><xref ref-type="bibr" rid="article-17369.r61">[61]</xref>&#x000a0;</p>
        <p>Patients with DI-AIN may present with the classic triad of rash, fever, and eosinophilia (in 10% of cases) but more often present with nonspecific symptoms such as fatigue, malaise, and nausea.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref><xref ref-type="bibr" rid="article-17369.r41">[41]</xref><xref ref-type="bibr" rid="article-17369.r62">[62]</xref>&#x000a0;When present,&#x000a0;rashes or skin eruptions are highly suggestive of DI-AIN. Skin manifestations are variable but most often described as a maculopapular or morbilliform rash, although diffuse erythroderma or even toxic epidermal necrolysis may be present.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r38">[38]</xref>&#x000a0;Many patients will demonstrate hypertension due to increased angiotensin II activity from interstitial inflammation, causing arterial vasoconstriction and increased water and sodium retention.<xref ref-type="bibr" rid="article-17369.r63">[63]</xref><xref ref-type="bibr" rid="article-17369.r64">[64]</xref><xref ref-type="bibr" rid="article-17369.r65">[65]</xref><xref ref-type="bibr" rid="article-17369.r66">[66]</xref><xref ref-type="bibr" rid="article-17369.r67">[67]</xref>&#x000a0;Patients are not usually oliguric until advanced AKI develops and may even be polyuric due to impaired tubular concentrating ability.<xref ref-type="bibr" rid="article-17369.r2">[2]</xref></p>
      </sec>
      <sec id="article-17369.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>AIN&#x000a0;and DI-AIN should be considered in the differential diagnosis of any patient with worsening renal function, especially if they have recently been exposed to new medications.&#x000a0;Worsening renal function, eosinophilia, increased levels of serum IgE, eosinophiluria, sterile pyuria, proteinuria, WBC casts in the urine, and microscopic hematuria are common laboratory findings.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref><xref ref-type="bibr" rid="article-17369.r2">[2]</xref>&#x000a0;While traditionally considered diagnostic of DI-AIN, eosinophiluria can no longer be considered a reliable test due to a sensitivity of 40% with a positive predictive value of just 38%.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r25">[25]</xref></p>
        <p>Proteinuria is frequently found in DI-AIN (40% of cases)&#x000a0;due to the release of a cytokine-like permeability-enhancing factor from interstitial inflammatory cells, preexisting underlying glomerular disease, or new glomerular injury from AIN-related cytokines.<xref ref-type="bibr" rid="article-17369.r2">[2]</xref><xref ref-type="bibr" rid="article-17369.r68">[68]</xref>&#x000a0;Nephrotic-range proteinuria (3 grams or more per day) is often encountered in NSAID-induced AIN.<xref ref-type="bibr" rid="article-17369.r16">[16]</xref></p>
        <p>One study found that glucosuria in patients without diabetes highly suggests tubular injury related to AIN and is often associated with low serum phosphorus, uric acid, and bicarbonate levels from impaired tubular reabsorption.<xref ref-type="bibr" rid="article-17369.r2">[2]</xref>&#x000a0;</p>
        <p>There is no available imaging test that will reliably diagnose patients for&#x000a0;AIN. Ultrasound or CT scans are frequently used to identify and exclude hydronephrosis or obstructive uropathy in cases of newly discovered azotemia but may show nonspecific kidney enlargement or enhanced echogenicity of the renal cortex in AIN.<xref ref-type="bibr" rid="article-17369.r3">[3]</xref><xref ref-type="bibr" rid="article-17369.r25">[25]</xref><xref ref-type="bibr" rid="article-17369.r42">[42]</xref></p>
        <p>
<bold>Investigational Tests</bold>
</p>
        <p>A higher ratio of urinary proinflammatory to anti-inflammatory macrophages has been suggested to help distinguish AIN from other renal disorders.<xref ref-type="bibr" rid="article-17369.r69">[69]</xref>&#x000a0;The lymphocyte transformation test measures the degree of lymphocytic proliferation in the presence of a specific medication. This can help identify the critical triggering drug in challenging situations such as cancer treatment, where discontinuing a critical chemotherapy agent can have serious consequences.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r70">[70]</xref></p>
        <p>Several urinary biomarkers are being investigated for possible use in diagnosing and monitoring AIN. These include&#x000a0;monocyte chemotactic peptide-1, alpha1-microglobulin, &#x003b2;2-microglobulin, KIM-1, sC5b-9, TNF-&#x003b1;, IL-9, and CXCL9.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref><xref ref-type="bibr" rid="article-17369.r57">[57]</xref><xref ref-type="bibr" rid="article-17369.r71">[71]</xref><xref ref-type="bibr" rid="article-17369.r72">[72]</xref><xref ref-type="bibr" rid="article-17369.r73">[73]</xref><xref ref-type="bibr" rid="article-17369.r74">[74]</xref><xref ref-type="bibr" rid="article-17369.r75">[75]</xref>&#x000a0;Of these, the most clinically promising appears to be the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>TNF-&#x003b1; and IL-9 are consistently elevated in patients with interstitial nephritis compared to other forms of kidney disease and normal controls.<xref ref-type="bibr" rid="article-17369.r75">[75]</xref><xref ref-type="bibr" rid="article-17369.r58">[58]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>CXCL9, an interstitial nephritis-promoting chemokine associated with lymphocytic chemotaxis, also appears quite promising as a biomarker for AIN, with urinary levels more than 7-fold higher in patients with the disorder than controls.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref><xref ref-type="bibr" rid="article-17369.r73">[73]</xref><xref ref-type="bibr" rid="article-17369.r76">[76]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17369.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In patients with suspected or confirmed&#x000a0;AIN or drug-induced interstitial nephritis, the mainstay of treatment is the withdrawal and discontinuation of the offending agent.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r77">[77]</xref><xref ref-type="bibr" rid="article-17369.r15">[15]</xref></p>
        <p>If the withdrawal of the likely offending drug does not result in a substantial improvement in renal function after 5 to 7 days, the consensus recommendation is to start the patient on corticosteroids.<xref ref-type="bibr" rid="article-17369.r7">[7]</xref><xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r41">[41]</xref><xref ref-type="bibr" rid="article-17369.r57">[57]</xref>&#x000a0;It is thought that AIN patients with high urinary biomarkers like IL-9, greater levels of interstitial inflammation, and lower degrees of chronic changes, such as fibrosis and tubular atrophy, on renal biopsy are likely to show the best response.<xref ref-type="bibr" rid="article-17369.r57">[57]</xref><xref ref-type="bibr" rid="article-17369.r58">[58]</xref>&#x000a0;</p>
        <p>Short-term dialysis is often needed in 30% to 69% of patients with DI-AIN, regardless of initial treatment.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref>&#x000a0;Treatment should also be directed at concurrent potentially nephrotoxic factors such as anemia, hyperglycemia, and hypertension to preserve renal function optimally.<xref ref-type="bibr" rid="article-17369.r5">[5]</xref></p>
        <p>Small case series&#x000a0;have evaluated&#x000a0;mycophenolate mofetil, cyclophosphamide, infliximab, azathioprine, and cyclosporine as therapeutic options in glucocorticoid-dependent&#x000a0;and steroid-resistant AIN patients.<xref ref-type="bibr" rid="article-17369.r78">[78]</xref><xref ref-type="bibr" rid="article-17369.r79">[79]</xref><xref ref-type="bibr" rid="article-17369.r80">[80]</xref><xref ref-type="bibr" rid="article-17369.r81">[81]</xref><xref ref-type="bibr" rid="article-17369.r82">[82]</xref><xref ref-type="bibr" rid="article-17369.r83">[83]</xref><xref ref-type="bibr" rid="article-17369.r84">[84]</xref>&#x000a0;Mycophenolate has been the most studied, but further investigations are needed&#x000a0;before this alternative approach can be generally recommended.<xref ref-type="bibr" rid="article-17369.r78">[78]</xref><xref ref-type="bibr" rid="article-17369.r85">[85]</xref></p>
      </sec>
      <sec id="article-17369.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of DI-AIN includes acute tubular necrosis; autoimmune-induced AIN; tubulointerstitial nephritis and uveitis syndrome (TINU); underlying systemic diseases, eg, sarcoidosis, SLE, Sjogren; lead or toxic metal exposure; glomerulonephritis, vasculitis; and pyelonephritis.</p>
        <p>Urine sediment, urine chemistries, and serum markers can be useful in distinguishing the above etiologies; however, the definitive diagnosis is a renal biopsy, which should be performed unless contraindicated in all patients without imminent renal recovery after medication discontinuation.</p>
      </sec>
      <sec id="article-17369.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of&#x000a0;AIN is favorable in cases&#x000a0;where a diagnosis has been made promptly, and exposure to the offending medication is minimized. AIN with renal failure for greater than&#x000a0;3 weeks portends a worse prognosis, likely due to the development of interstitial fibrosis and tubular damage.&#x000a0;NSAID-related AIN is also associated with a somewhat worse outcome.&#x000a0;AIN due to proton pump inhibitors has been linked to lower severity of acute kidney injury&#x000a0;but with a reduced likelihood of recovery at&#x000a0;6 months. This has been attributed to the possibility of prolonged drug exposure.</p>
        <p>One series revealed that 26% of patients with AIN ultimately returned to their baseline renal function, while 4% required long-term renal replacement therapy.&#x000a0;It is estimated that 40% to 60% of patients with biopsy-proven AIN will not fully recover their baseline renal function when assessed six months after biopsy.<xref ref-type="bibr" rid="article-17369.r58">[58]</xref> Lack of recovery is associated with lower GFR and albuminuria before DI-AIN, longer exposure to the attributable drug, and greater fibrosis, granulomas, or tubular atrophy on biopsy.<xref ref-type="bibr" rid="article-17369.r24">[24]</xref><xref ref-type="bibr" rid="article-17369.r57">[57]</xref><xref ref-type="bibr" rid="article-17369.r58">[58]</xref><xref ref-type="bibr" rid="article-17369.r86">[86]</xref></p>
      </sec>
      <sec id="article-17369.s12" sec-type="Complications">
        <title>Complications</title>
        <p>In most instances, suspected DI-AIN resolves, as treating the underlying issue resolves the problem. Renal failure may persist for weeks or months, but recovery usually occurs within the first 3 months. AIN can progress into chronic kidney damage or even end-stage renal failure. This complication is more likely in older patients and those with preexisting kidney disorders. Hypertension may develop from increased angiotensin II production.&#x000a0;<xref ref-type="bibr" rid="article-17369.r67">[67]</xref> Anemia can be caused by decreased erythropoietin production, end-organ unresponsiveness, or hemolytic processes and should be monitored.<xref ref-type="bibr" rid="article-17369.r62">[62]</xref></p>
      </sec>
      <sec id="article-17369.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients need to understand the underlying cause of their condition and strictly comply with all directions towards ameliorating the condition, usually by removing the offending agent. If started on steroids, they need to be aware of the need to taper the dosage over time and not stop the medication before the prescribed course duration. Patients should also be informed of the nature of their new "allergy" and that future lifetime avoidance of the triggering medication is necessary.</p>
      </sec>
      <sec id="article-17369.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>A BUN/creatinine ratio of 12 or less is a good, quick, easy test that suggests interstitial nephritis but not necessarily which type. An elevated IgE and a low BUN/creatinine ratio would strongly suggest AIN. Eosinophilia and eosinophiluria suggest&#x000a0;AIN and DI-AIN, except in NSAID-induced disease, in which proteinuria is the predominant lab abnormality.</p>
        <p>Early steroid use appears to be beneficial.<xref ref-type="bibr" rid="article-17369.r15">[15]</xref><xref ref-type="bibr" rid="article-17369.r87">[87]</xref><xref ref-type="bibr" rid="article-17369.r88">[88]</xref><xref ref-type="bibr" rid="article-17369.r89">[89]</xref>&#x000a0;If the differential diagnoses contain only disorders for which steroids would be therapeutic, there may be little reason&#x000a0;to wait for&#x000a0;the usual 5 to 7 days after medication withdrawal before starting therapy in the more severe cases.</p>
      </sec>
      <sec id="article-17369.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>AIN should be considered in the differential diagnosis of any patient with worsening renal function or newly discovered azotemia.&#x000a0;A careful, focused, and comprehensive medication history, including OTC drugs, should be obtained, and a thorough physical examination should look for unexplained or new arthralgias, flank pain, fever, and rashes.&#x000a0;</p>
        <p>Close cooperation and communication among the interprofessional healthcare team will help optimize patient outcomes. Clinicians who prescribe medications should be aware of those with a high potential for causing AIN and which patients might be at higher risk, such as&#x000a0;older individuals. A careful and thorough medication history should be obtained and verified by all members of the clinical healthcare team, including nurses and pharmacists. Adverse reactions, including those associated with AIN, should be identified and reported. Patients should be aware of the importance of reporting possible adverse reactions so their healthcare team can take appropriate action.</p>
        <p>Nephrologists should be involved in any patient with newly discovered azotemia to advise on drug management, therapeutic steroid use, differential diagnoses for AKI, and the need and timing for a kidney biopsy. Interventional radiology or nephrology may need to be involved to perform the actual biopsy, while pathology will evaluate the specimen histologically to confirm the presence of AIN.&#x000a0;</p>
        <p>Close coordination, communication, and cooperation within the interprofessional healthcare team (primary care physicians, nephrologists, pharmacists, dermatologists, histopathologists, nurses, and other professionals) will help improve patient care, preserve renal function, avoid end-stage renal disease, and optimize outcomes.</p>
      </sec>
      <sec id="article-17369.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17369&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17369">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17369/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17369">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17369.s17">
        <title>References</title>
        <ref id="article-17369.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Drug-Induced Acute Interstitial Nephritis.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2017</year>
            <month>Dec</month>
            <day>07</day>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>2046</fpage>
            <page-range>2046-2049</page-range>
            <pub-id pub-id-type="pmid">28893923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Non-diabetic glycosuria as a diagnostic clue for acute tubulointerstitial nephritis in patients with azotemia.</article-title>
            <source>Ren Fail</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>1015</fpage>
            <page-range>1015-1021</page-range>
            <pub-id pub-id-type="pmid">32985319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Markowitz</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced acute interstitial nephritis.</article-title>
            <source>Nat Rev Nephrol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>6</volume>
            <issue>8</issue>
            <fpage>461</fpage>
            <page-range>461-70</page-range>
            <pub-id pub-id-type="pmid">20517290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dobrek</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A Synopsis of Current Theories on Drug-Induced Nephrotoxicity.</article-title>
            <source>Life (Basel)</source>
            <year>2023</year>
            <month>Jan</month>
            <day>24</day>
            <volume>13</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">36836682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Awdishu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>The 6R's of drug induced nephrotoxicity.</article-title>
            <source>BMC Nephrol</source>
            <year>2017</year>
            <month>Apr</month>
            <day>03</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>124</fpage>
            <pub-id pub-id-type="pmid">28372552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nolan</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Abernathy</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Nephropathy associated with methicillin therapy. Prevalence and determinants in patients with staphylococcal bacteremia.</article-title>
            <source>Arch Intern Med</source>
            <year>1977</year>
            <month>Aug</month>
            <volume>137</volume>
            <issue>8</issue>
            <fpage>997</fpage>
            <page-range>997-1000</page-range>
            <pub-id pub-id-type="pmid">879956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r7">
          <label>7</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bhandari</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thada</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Arif</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <chapter-title>Tubulointerstitial Nephritis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">32491469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaudreault-Tremblay</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Litalien</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Patey</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Merouani</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Severe Acute Kidney Injury and Multiple Organ Failure in a 17-Day-Old Newborn: When Pathology Makes the Difference.</article-title>
            <source>Can J Kidney Health Dis</source>
            <year>2018</year>
            <volume>5</volume>
            <fpage>2054358118804834</fpage>
            <pub-id pub-id-type="pmid">30305914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Finnigan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Rout</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Bashir</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Allergic and Drug-Induced Interstitial Nephritis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>9</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">29493948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>PPIs and kidney disease: from AIN to CKD.</article-title>
            <source>J Nephrol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>611</fpage>
            <page-range>611-6</page-range>
            <pub-id pub-id-type="pmid">27072818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x0017d;ivn&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Bare&#x00161;ov&#x000e1;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>H&#x0016f;lkov&#x000e1;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kmoch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bleyer</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Autosomal dominant tubulointerstitial kidney disease: A review.</article-title>
            <source>Am J Med Genet C Semin Med Genet</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>190</volume>
            <issue>3</issue>
            <fpage>309</fpage>
            <page-range>309-324</page-range>
            <pub-id pub-id-type="pmid">36250282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Shamam</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Hashmi</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <chapter-title>Autosomal Dominant Tubulointerstitial Kidney Disease</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">33760469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clarkson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Giblin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>O'Kelly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Walshe</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Conlon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>O'Meara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dormon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Donohoe</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acute interstitial nephritis: clinical features and response to corticosteroid therapy.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>2778</fpage>
            <page-range>2778-83</page-range>
            <pub-id pub-id-type="pmid">15340098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Vriese</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Robbrecht</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Vanholder</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Vogelaers</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Lameire</surname>
                <given-names>NH</given-names>
              </name>
            </person-group>
            <article-title>Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features.</article-title>
            <source>Am J Kidney Dis</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>108</fpage>
            <page-range>108-15</page-range>
            <pub-id pub-id-type="pmid">9428460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanchez-Alamo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cases-Corona</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fernandez-Juarez</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Facing the Challenge of Drug-Induced Acute Interstitial Nephritis.</article-title>
            <source>Nephron</source>
            <year>2023</year>
            <volume>147</volume>
            <issue>2</issue>
            <fpage>78</fpage>
            <page-range>78-90</page-range>
            <pub-id pub-id-type="pmid">35830831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000e9;rida</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Praga</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>NSAIDs and Nephrotic Syndrome.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2019</year>
            <month>Sep</month>
            <day>06</day>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>1280</fpage>
            <page-range>1280-1282</page-range>
            <pub-id pub-id-type="pmid">31416889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Praga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Acute interstitial nephritis.</article-title>
            <source>Kidney Int</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>77</volume>
            <issue>11</issue>
            <fpage>956</fpage>
            <page-range>956-61</page-range>
            <pub-id pub-id-type="pmid">20336051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mann</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Goerig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brune</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Luft</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Ibuprofen as an over-the-counter drug: is there a risk for renal injury?</article-title>
            <source>Clin Nephrol</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">8428401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pamuk</surname>
                <given-names>ON</given-names>
              </name>
              <name>
                <surname>Cakir</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The renal effects of the addition of low-dose aspirin to COX-2 selective and nonselective antiinflammatory drugs.</article-title>
            <source>Clin Rheumatol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>123</fpage>
            <page-range>123-5</page-range>
            <pub-id pub-id-type="pmid">16175430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blank</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Parkin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Herbison</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use.</article-title>
            <source>Kidney Int</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>86</volume>
            <issue>4</issue>
            <fpage>837</fpage>
            <page-range>837-44</page-range>
            <pub-id pub-id-type="pmid">24646856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nast</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Medication-Induced Interstitial Nephritis in the 21st Century.</article-title>
            <source>Adv Chronic Kidney Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>72</fpage>
            <page-range>72-79</page-range>
            <pub-id pub-id-type="pmid">28284382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sierra</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Suarez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vela</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Systematic review: Proton pump inhibitor-associated acute interstitial nephritis.</article-title>
            <source>Aliment Pharmacol Ther</source>
            <year>2007</year>
            <month>Aug</month>
            <day>15</day>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>545</fpage>
            <page-range>545-53</page-range>
            <pub-id pub-id-type="pmid">17661758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muriithi</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Valeri</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Cornell</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fidler</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Nasr</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly.</article-title>
            <source>Kidney Int</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>458</fpage>
            <page-range>458-64</page-range>
            <pub-id pub-id-type="pmid">25185078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muriithi</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Valeri</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Cornell</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Sethi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fidler</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Nasr</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Biopsy-proven acute interstitial nephritis, 1993-2011: a&#x000a0;case&#x000a0;series.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>558</fpage>
            <page-range>558-66</page-range>
            <pub-id pub-id-type="pmid">24927897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kodner</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kudrimoti</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of acute interstitial nephritis.</article-title>
            <source>Am Fam Physician</source>
            <year>2003</year>
            <month>Jun</month>
            <day>15</day>
            <volume>67</volume>
            <issue>12</issue>
            <fpage>2527</fpage>
            <page-range>2527-34</page-range>
            <pub-id pub-id-type="pmid">12825841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barreto</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Rule</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Management of Drug-Associated Acute Interstitial Nephritis.</article-title>
            <source>Kidney360</source>
            <year>2020</year>
            <month>Jan</month>
            <day>30</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>62</fpage>
            <page-range>62-64</page-range>
            <pub-id pub-id-type="pmid">35372864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Draibe</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Carro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martinez-Valenzuela</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Agraz</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fulladosa</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Bolufer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tango</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Torras</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Soler</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Acute tubulointerstitial nephritis induced by checkpoint inhibitors versus classical acute tubulointerstitial nephritis: are they the same disease?</article-title>
            <source>Clin Kidney J</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>884</fpage>
            <page-range>884-890</page-range>
            <pub-id pub-id-type="pmid">33777371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cortazar</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Marrone</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Troxell</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Ralto</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Hoenig</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Brahmer</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Lipson</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Glezerman</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Wolchok</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cornell</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stokes</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Zapata</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Hodi</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Ott</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Leaf</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.</article-title>
            <source>Kidney Int</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>90</volume>
            <issue>3</issue>
            <fpage>638</fpage>
            <page-range>638-47</page-range>
            <pub-id pub-id-type="pmid">27282937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brahmer</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lacchetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Atkins</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Brassil</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Caterino</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Chau</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ernstoff</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ginex</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hallmeyer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Holter Chakrabarty</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leighl</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Mammen</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Naing</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nastoupil</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Puzanov</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Reichner</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Santomasso</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Seigel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Spira</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Suarez-Almazor</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wolchok</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>JA</given-names>
              </name>
              <collab>National Comprehensive Cancer Network</collab>
            </person-group>
            <article-title>Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.</article-title>
            <source>J Clin Oncol</source>
            <year>2018</year>
            <month>Jun</month>
            <day>10</day>
            <volume>36</volume>
            <issue>17</issue>
            <fpage>1714</fpage>
            <page-range>1714-1768</page-range>
            <pub-id pub-id-type="pmid">29442540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cortazar</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Kibbelaar</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Glezerman</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Abudayyeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mamlouk</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Motwani</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Murakami</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Manohar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shirali</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Kitchlu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shirazian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Assal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vijayan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Renaghan</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Ortiz-Melo</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Rangarajan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Dinh</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Marrone</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Mithani</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Hosseini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uprety</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Sise</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Leaf</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>435</fpage>
            <page-range>435-446</page-range>
            <pub-id pub-id-type="pmid">31896554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Proton Pump Inhibitors and CKD.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>2926</fpage>
            <page-range>2926-2928</page-range>
            <pub-id pub-id-type="pmid">27080978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seethapathy</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chute</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Zubiri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Oppong</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Strohbehn</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cortazar</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Leaf</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Mooradian</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Villani</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sise</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2019</year>
            <month>Dec</month>
            <day>06</day>
            <volume>14</volume>
            <issue>12</issue>
            <fpage>1692</fpage>
            <page-range>1692-1700</page-range>
            <pub-id pub-id-type="pmid">31672794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raghavan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shawar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of Drug-Induced Interstitial Nephritis.</article-title>
            <source>Adv Chronic Kidney Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>64</fpage>
            <page-range>64-71</page-range>
            <pub-id pub-id-type="pmid">28284381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lomboy</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Jose</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Allergic Interstitial Nephritis Masquerading as Pyelonephritis in a Pediatric Patient With Crohn Disease.</article-title>
            <source>J Pediatr Gastroenterol Nutr</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>e18</fpage>
            <page-range>e18-e20</page-range>
            <pub-id pub-id-type="pmid">28644363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Sabri</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Cathro</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Sodium Tetradecyl Sulfate-Induced Acute Allergic Interstitial Nephritis.</article-title>
            <source>Cardiovasc Intervent Radiol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>40</volume>
            <issue>7</issue>
            <fpage>1125</fpage>
            <page-range>1125-1128</page-range>
            <pub-id pub-id-type="pmid">28357570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alsaad</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Dhannoon</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Pantin</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Rare allergic reaction of the kidney: sitagliptin-induced acute tubulointerstitial nephritis.</article-title>
            <source>BMJ Case Rep</source>
            <year>2016</year>
            <month>Jul</month>
            <day>19</day>
            <volume>2016</volume>
            <pub-id pub-id-type="pmid">27436034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davison</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Acute interstitial nephritis in the elderly: a report from the UK MRC Glomerulonephritis Register and a review of the literature.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>1998</year>
            <volume>13 Suppl 7</volume>
            <fpage>12</fpage>
            <page-range>12-6</page-range>
            <pub-id pub-id-type="pmid">9870431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Praga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sevillano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Au&#x000f1;&#x000f3;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>9</issue>
            <fpage>1472</fpage>
            <page-range>1472-9</page-range>
            <pub-id pub-id-type="pmid">25324356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spargo</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Wit</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Meehan</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>433</fpage>
            <page-range>433-47</page-range>
            <pub-id pub-id-type="pmid">10692269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hosohata</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Role of Oxidative Stress in Drug-Induced Kidney Injury.</article-title>
            <source>Int J Mol Sci</source>
            <year>2016</year>
            <month>Nov</month>
            <day>01</day>
            <volume>17</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">27809280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r41">
          <label>41</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Naik</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Annamaraju</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Interstitial Nephritis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>1</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">33232019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishnan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment.</article-title>
            <source>Iran J Kidney Dis</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-13</page-range>
            <pub-id pub-id-type="pmid">25599729</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spanou</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Britschgi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yawalkar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fehr</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Neuweiler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gugger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mohaupt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pichler</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Involvement of drug-specific T cells in acute drug-induced interstitial nephritis.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>17</volume>
            <issue>10</issue>
            <fpage>2919</fpage>
            <page-range>2919-27</page-range>
            <pub-id pub-id-type="pmid">16943303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelly</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Neilson</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>Contrasuppression in autoimmunity. Abnormal contrasuppression facilitates expression of nephritogenic effector T cells and interstitial nephritis in kdkd mice.</article-title>
            <source>J Exp Med</source>
            <year>1987</year>
            <month>Jan</month>
            <day>01</day>
            <volume>165</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-23</page-range>
            <pub-id pub-id-type="pmid">2947967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pichler</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept.</article-title>
            <source>Curr Opin Allergy Clin Immunol</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>301</fpage>
            <page-range>301-5</page-range>
            <pub-id pub-id-type="pmid">12130944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitching</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Hutton</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>The Players: Cells Involved in Glomerular Disease.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2016</year>
            <month>Sep</month>
            <day>07</day>
            <volume>11</volume>
            <issue>9</issue>
            <fpage>1664</fpage>
            <page-range>1664-1674</page-range>
            <pub-id pub-id-type="pmid">27073196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buysen</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Houthoff</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Krediet</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Arisz</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Acute interstitial nephritis: a clinical and morphological study in 27 patients.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>1990</year>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>94</fpage>
            <page-range>94-9</page-range>
            <pub-id pub-id-type="pmid">2113219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerber</surname>
                <given-names>BO</given-names>
              </name>
              <name>
                <surname>Pichler</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Cellular mechanisms of T cell mediated drug hypersensitivity.</article-title>
            <source>Curr Opin Immunol</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>732</fpage>
            <page-range>732-7</page-range>
            <pub-id pub-id-type="pmid">15511665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossert</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced acute interstitial nephritis.</article-title>
            <source>Kidney Int</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>804</fpage>
            <page-range>804-17</page-range>
            <pub-id pub-id-type="pmid">11473672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rastegar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kashgarian</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Long-term analgesic use and renal disease.</article-title>
            <source>Kidney Int</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>743</fpage>
            <pub-id pub-id-type="pmid">9987102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rojas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Restrepo-Jim&#x000e9;nez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Monsalve</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Pacheco</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Acosta-Ampudia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ram&#x000ed;rez-Santana</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>PSC</given-names>
              </name>
              <name>
                <surname>Ansari</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Gershwin</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Anaya</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Molecular mimicry and autoimmunity.</article-title>
            <source>J Autoimmun</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>95</volume>
            <fpage>100</fpage>
            <page-range>100-123</page-range>
            <pub-id pub-id-type="pmid">30509385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rosner</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Drug-Induced Acute Kidney Injury.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>8</issue>
            <fpage>1220</fpage>
            <page-range>1220-1233</page-range>
            <pub-id pub-id-type="pmid">35273009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Border</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Egan</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Sass</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Glode</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis.</article-title>
            <source>N Engl J Med</source>
            <year>1974</year>
            <month>Aug</month>
            <day>22</day>
            <volume>291</volume>
            <issue>8</issue>
            <fpage>381</fpage>
            <page-range>381-4</page-range>
            <pub-id pub-id-type="pmid">4211170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheng</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Nolasco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hildreth</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Neild</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Hartley</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>HLA-DR display by renal tubular epithelium and phenotype of infiltrate in interstitial nephritis.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>1989</year>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-15</page-range>
            <pub-id pub-id-type="pmid">2498779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title><italic>HLA-DQA1</italic>, <italic>-DQB1</italic>, and <italic>-DRB1</italic> Alleles Associated with Acute Tubulointerstitial Nephritis in a Chinese Population: A Single-Center Cohort Study.</article-title>
            <source>J Immunol</source>
            <year>2018</year>
            <month>Jul</month>
            <day>15</day>
            <volume>201</volume>
            <issue>2</issue>
            <fpage>423</fpage>
            <page-range>423-431</page-range>
            <pub-id pub-id-type="pmid">29858267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marco</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Anna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Annalisa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Francesco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stefania</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Stella</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Michele</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marco</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Loreto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma.</article-title>
            <source>Ther Adv Med Oncol</source>
            <year>2019</year>
            <volume>11</volume>
            <fpage>1758835919875549</fpage>
            <pub-id pub-id-type="pmid">31579108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>The Challenges of Acute Interstitial Nephritis: Time to Standardize.</article-title>
            <source>Kidney360</source>
            <year>2021</year>
            <month>Jun</month>
            <day>24</day>
            <volume>2</volume>
            <issue>6</issue>
            <fpage>1051</fpage>
            <page-range>1051-1055</page-range>
            <pub-id pub-id-type="pmid">35373086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Kukova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Obeid</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Luciano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kuperman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moeckel</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Kashgarian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Cantley</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Urine interleukin-9 and tumor necrosis factor-&#x003b1; for prognosis of human acute interstitial nephritis.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2021</year>
            <month>Sep</month>
            <day>27</day>
            <volume>36</volume>
            <issue>10</issue>
            <fpage>1851</fpage>
            <page-range>1851-1858</page-range>
            <pub-id pub-id-type="pmid">33125471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moinuddin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bracamonte</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thajudeen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sussman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Madhrira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Costello</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Allergic Interstitial Nephritis Manifesting as a Striated Nephrogram.</article-title>
            <source>Case Rep Med</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>250530</fpage>
            <pub-id pub-id-type="pmid">26664405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Humayun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Norris</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Monga</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lewin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>F&#x000fc;l&#x000f6;p</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Kidney biopsy for renal tubular acidosis: when&#x000a0;tissue diagnosis makes a difference.</article-title>
            <source>Clin Nephrol Case Stud</source>
            <year>2015</year>
            <volume>3</volume>
            <fpage>1</fpage>
            <page-range>1-4</page-range>
            <pub-id pub-id-type="pmid">29043125</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sulaiman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Locati</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sidhu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sangha</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Allergic interstitial nephritis due to ceftaroline.</article-title>
            <source>Am J Med Sci</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>348</volume>
            <issue>4</issue>
            <fpage>354</fpage>
            <page-range>354-5</page-range>
            <pub-id pub-id-type="pmid">25192358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial Disease.</article-title>
            <source>Adv Chronic Kidney Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>57</fpage>
            <page-range>57-63</page-range>
            <pub-id pub-id-type="pmid">28284380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Broe</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Elseviers</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Over-the-counter analgesic use.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>10</issue>
            <fpage>2098</fpage>
            <page-range>2098-103</page-range>
            <pub-id pub-id-type="pmid">19423685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Iturbe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Role of inflammatory cells in the kidney in the induction and maintenance of hypertension.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>260</fpage>
            <page-range>260-3</page-range>
            <pub-id pub-id-type="pmid">16326746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaziri</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension.</article-title>
            <source>Curr Opin Nephrol Hypertens</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-9</page-range>
            <pub-id pub-id-type="pmid">15090865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Iturbe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Quiroz</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ferrebuz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vaziri</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats.</article-title>
            <source>Am J Nephrol</source>
            <year>2004</year>
            <season>Nov-Dec</season>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>587</fpage>
            <page-range>587-94</page-range>
            <pub-id pub-id-type="pmid">15564764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Franco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Iturbe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Santamar&#x000ed;a</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Montoya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nepomuceno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bautista</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tapia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Herrera-Acosta</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Angiotensin II, interstitial inflammation, and the pathogenesis of salt-sensitive hypertension.</article-title>
            <source>Am J Physiol Renal Physiol</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>291</volume>
            <issue>6</issue>
            <fpage>F1281</fpage>
            <page-range>F1281-7</page-range>
            <pub-id pub-id-type="pmid">16868307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghosh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>RG</given-names>
              </name>
              <collab>Usha</collab>
              <name>
                <surname>Behura</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Soni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharatchandra</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Interstitial nephritis with moderate-to-heavy proteinuria: an unusual combination.</article-title>
            <source>Saudi J Kidney Dis Transpl</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>397</fpage>
            <page-range>397-402</page-range>
            <pub-id pub-id-type="pmid">22382248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SX</given-names>
              </name>
              <name>
                <surname>Nie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Urine macrophages reflect kidney macrophage content during acute tubular interstitial and glomerular injury.</article-title>
            <source>Clin Immunol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>205</volume>
            <fpage>65</fpage>
            <page-range>65-74</page-range>
            <pub-id pub-id-type="pmid">31212026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Nivolumab-induced acute tubular injury: A case report.</article-title>
            <source>Clin Case Rep</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>e6991</fpage>
            <pub-id pub-id-type="pmid">36911644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joyce</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Glasner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ranganathan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Swiatecka-Urban</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Tubulointerstitial nephritis: diagnosis, treatment, and monitoring.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>577</fpage>
            <page-range>577-587</page-range>
            <pub-id pub-id-type="pmid">27155873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hettinga</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Scheerlinck</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Lilien</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Rothova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Boer</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>The value of measuring urinary &#x003b2;2-microglobulin and serum creatinine for detecting tubulointerstitial nephritis and uveitis syndrome in young patients with uveitis.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>133</volume>
            <issue>2</issue>
            <fpage>140</fpage>
            <page-range>140-5</page-range>
            <pub-id pub-id-type="pmid">25356569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Canney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Hiremath</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Biomarkers in acute kidney injury: On the cusp of a new era?</article-title>
            <source>J Clin Invest</source>
            <year>2023</year>
            <month>Jul</month>
            <day>03</day>
            <volume>133</volume>
            <issue>13</issue>
            <pub-id pub-id-type="pmid">37395275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martinez Valenzuela</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Draibe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bestard</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Fulladosa</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Preciado</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ant&#x000f3;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nadal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jov&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cruzado</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Torras</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Urinary Cytokines Reflect Renal Inflammation in Acute Tubulointerstitial Nephritis: A Multiplex Bead-Based Assay Assessment.</article-title>
            <source>J Clin Med</source>
            <year>2021</year>
            <month>Jul</month>
            <day>04</day>
            <volume>10</volume>
            <issue>13</issue>
            <pub-id pub-id-type="pmid">34279469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Pober</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Luciano</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Obeid</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kuperman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moeckel</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Kashgarian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cantley</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Urine TNF-&#x003b1; and IL-9 for clinical diagnosis of acute interstitial nephritis.</article-title>
            <source>JCI Insight</source>
            <year>2019</year>
            <month>May</month>
            <day>16</day>
            <volume>4</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">31092735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moledina</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Obeid</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Rosales</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sise</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Moeckel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kashgarian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuperman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Lefferts</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Meliambro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bitzer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perazella</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Luciano</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Pober</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Cantley</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Colvin</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis.</article-title>
            <source>J Clin Invest</source>
            <year>2023</year>
            <month>Jul</month>
            <day>03</day>
            <volume>133</volume>
            <issue>13</issue>
            <pub-id pub-id-type="pmid">37395276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caravaca-Font&#x000e1;n</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Ju&#x000e1;rez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Praga</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acute kidney injury in interstitial nephritis.</article-title>
            <source>Curr Opin Crit Care</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>558</fpage>
            <page-range>558-564</page-range>
            <pub-id pub-id-type="pmid">31503026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galesi&#x00107;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Prkacin</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tisljar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Horvati&#x00107;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ljubanovi&#x00107;</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>[Drug induced allergic interstitial nephritis].</article-title>
            <source>Lijec Vjesn</source>
            <year>2011</year>
            <season>Jul-Aug</season>
            <volume>133</volume>
            <issue>7-8</issue>
            <fpage>276</fpage>
            <page-range>276-83</page-range>
            <pub-id pub-id-type="pmid">22165196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preddie</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Markowitz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Radhakrishnan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nickolas</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>D'Agati</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Schwimmer</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gardenswartz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Appel</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Mycophenolate mofetil for the treatment of interstitial nephritis.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>718</fpage>
            <page-range>718-22</page-range>
            <pub-id pub-id-type="pmid">17699278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Iturbe</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Is mycophenolate mofetil a new treatment option in acute interstitial nephritis?</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>609</fpage>
            <page-range>609-10</page-range>
            <pub-id pub-id-type="pmid">17699264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Protective effect of cyclosporine on inflammatory injury of renal tubular epithelial cells.</article-title>
            <source>Eur Rev Med Pharmacol Sci</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>19</issue>
            <fpage>6551</fpage>
            <page-range>6551-6559</page-range>
            <pub-id pub-id-type="pmid">30338826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Combination Cyclophosphamide/Glucocorticoids Provide Better Tolerability and Outcomes versus Glucocorticoids Alone in Patients with Sjogren's Associated Chronic Interstitial Nephritis.</article-title>
            <source>Am J Nephrol</source>
            <year>2017</year>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>473</fpage>
            <page-range>473-480</page-range>
            <pub-id pub-id-type="pmid">29241210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsuoka-Uchiyama</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mifune</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawakita</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2021</year>
            <month>Dec</month>
            <day>17</day>
            <volume>100</volume>
            <issue>50</issue>
            <fpage>e28252</fpage>
            <pub-id pub-id-type="pmid">34918693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Mamlouk</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Selamet</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Tchakarov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Glass</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Sheth</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Layman</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Dadu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abdelwahab</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Abdelrahim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Diab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abudayyeh</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis.</article-title>
            <source>Oncoimmunology</source>
            <year>2021</year>
            <month>Feb</month>
            <day>02</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>1877415</fpage>
            <pub-id pub-id-type="pmid">33643693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhat</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tonutti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Timilsina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Selmi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gershwin</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-100</page-range>
            <pub-id pub-id-type="pmid">37338709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simpson</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Pilmore</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Manley</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thein</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Voss</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases.</article-title>
            <source>Nephrology (Carlton)</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>381</fpage>
            <page-range>381-5</page-range>
            <pub-id pub-id-type="pmid">17014549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Surendra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Raju</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chandragiri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uppin</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Raju</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Steroid therapy in drug induced acute interstitial nephritis- Retrospective analysis of 83 cases.</article-title>
            <source>Saudi J Kidney Dis Transpl</source>
            <year>2019</year>
            <season>Jan-Feb</season>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>157</fpage>
            <page-range>157-165</page-range>
            <pub-id pub-id-type="pmid">30804277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guti&#x000e9;rrez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Galeano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chevia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>de Sequera</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bernis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parra</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sanz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ortiz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goicoechea</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quereda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Olea</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bouarich</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Segovia</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Praga</surname>
                <given-names>M</given-names>
              </name>
              <collab>Grupo Madrile&#x000f1;o De Nefritis Intersticiales</collab>
            </person-group>
            <article-title>Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis.</article-title>
            <source>Kidney Int</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>73</volume>
            <issue>8</issue>
            <fpage>940</fpage>
            <page-range>940-6</page-range>
            <pub-id pub-id-type="pmid">18185501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17369.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramachandran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nada</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jha</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Kohli</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced acute interstitial nephritis: A clinicopathological study and comparative trial of steroid regimens.</article-title>
            <source>Indian J Nephrol</source>
            <year>2015</year>
            <season>Sep-Oct</season>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>281</fpage>
            <page-range>281-6</page-range>
            <pub-id pub-id-type="pmid">26628793</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
